RIMBP2 and small cell lung carcinoma: In this study, SCLC patients with low expression of RIMBP2 (RIMS Binding Protein 2), a protein predicted to be involved in neuromuscular synaptic transmission, had a poor prognosis, consistent with results previously obtained in lung squamous cell carcinoma patients [79].